Ankerstar Wealth’s Edwards Lifesciences EW Stock Holding History

Ankerstar Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$2.16K	–	1013
2026 Q1	$2.16K	Hold	27	–	–	﹤0.01%	364
2025 Q4	$2.3K	Buy	+27	New	+$2.22K	﹤0.01%	393

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Ankerstar Wealth's EW Position: Q2 2026 in Review

Ankerstar Wealth sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 27 shares — an estimated $2.16K sold.

Ankerstar Wealth first reported a position in EW in Q4 2025 and held it in 2 quarters. The position peaked at $2.3K in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Ankerstar Wealth reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Ankerstar Wealth sold 27 Edwards Lifesciences shares in Q2 2026, an estimated $2.16K.
Ankerstar Wealth first reported a position in Edwards Lifesciences in Q4 2025 and held it in 2 quarters.
Ankerstar Wealth's Edwards Lifesciences position peaked at $2.3K in Q4 2025.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.